Agency Forms Undergoing Paperwork Reduction Act Review, 2524-2525 [2019-01322]
Download as PDF
<![CDATA[
2524
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
Coordination (CVJ16) and insert the
following:
Office of Policy, Planning and
Partnerships (CVJ16). (1) Identifies
program priorities through strategic
planning and other processes as
appropriate; (2) oversees the
development of the center’s
performance plan and performance
reports to ensure accountability and
improve programs and activities; (3)
coordinates with the center director,
deputy director and management officer
on the formulation of the NCHHSTP
budget; (4) liaises with the CDC
Business Services Offices on
congressional, legislative, and other
inquiries; (5) maintains liaison with
Congress on matters including
appropriations, legislative bill tracking,
and legislative requests, testimony for
hearings, congressional inquiries, etc.;
(6) develops policy- and programrelated materials for internal and
external stakeholders; (7) oversees the
preparation and routing of controlled
correspondence; (8) maintains liaison
with key CDC offices and individuals
working on public health policies and
legislative issues; (9) serves as liaison to
governmental and nongovernmental
partners on policy-related issues; (10)
oversees coordination of CDC OD
engagement requests, executive or
legislative branch issues, and
management efforts; (11) conducts
analysis related to short- and long-term
CIO priorities; (12) develops and
manages partnership activities,
including non-governmental and private
sector organizations; (13) develops longterm partnership and policy
development plans across CIO divisions
and in coordination with center OD
offices; (14) disseminates information to
CIO leadership and staff, as appropriate,
on policy, planning and partner
engagement situation analyses; (15)
coordinates the completion of Freedom
of Information Act requests, supporting
CIO Divisions; (16) coordinates with
Health Communication Science Office
to disseminate information to partner
organizations; (17) manages two federal
advisory committees for CIO; and (18)
coordinates risk mitigation activities
across CIO.
After the functional statement for the
Office of Program Planning and Policy
Coordination (CVJ16), insert the
following:
Health Communication Science Office
(CVJ17). (1) Serves as the principal
advisor to NCHHSTP on communication
and marketing practice, research, and
science; (2) provides oversight to ensure
the quality of health communication
and marketing campaigns and products
created by NCHHSTP and its divisions;
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
(3) serves as NCHHSTP clearance office
for health communication campaigns
and products; develops and manages
clearance systems; (4) provides strategic
planning and coordination for
NCHHSTP strategic communication and
social marketing programs in
collaboration with OD and divisionlevel staff; (5) collaborates with
NCHHSTP divisions and center policy
staff to ensure consistent and timely
translation of center-specific scientific
findings and recommendations for
messages and materials effective for the
news media, social media, partner, and
other communication channels; (6)
coordinates and provides center input
on communication activities; (7)
coordinates CDC and NCHHSTP brand
management and logo licensing; (8)
provides oversight and consultation on
partner/stakeholder communication; (9)
provides oversight, consultation, and
strategic coordination on partnership
development and relationships in
collaboration with NCHHSTP divisions
and CDC CIOs for the National
Prevention Information Network; (10)
manages communication infrastructure
for NCHHSTP partnerships; (11)
oversees management, policy guidance,
and governance of NCHHSTP digital
channels and websites per HHS and
CDC policy for the use of
communication platforms; (12) provides
coordination and conducts activities to
support NCHHSTP’s presence on
networked media, including social,
mobile, and traditional media; (13)
collects/analyzes user data/metrics from
communication channels and
technologies to assess system
performance, usability, accessibility,
and usefulness; (14) formulates strategic
communication objectives for advancing
program priorities and addressing
identified long-range issues through
news media, partner, and other
communication strategies; (15) oversees
the implementation of strategic
communication plans through several
functional areas; (16) develops and
implements all proactive media
outreach and reactive media responses
for the center; (17) provides media
training and technical assistance, as
appropriate; and (18) serves as liaison to
key offices for obtaining CDC and HHS
media clearance on products/activities.
Sherri A. Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01321 Filed 2–6–19; 8:45 am]
BILLING CODE 4160–18–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–19–18AAE]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Barriers and
Facilitators to Expanding the NHBS to
Conduct HIV Behavioral Surveillance
Among Transgender Women (NHBSTrans) to the Office of Management and
Budget (OMB) for review and approval.
CDC previously published a ‘‘Proposed
Data Collection Submitted for Public
Comment and Recommendations’’
notice on May 29, 2018 to obtain
comments from the public and affected
agencies. The notice was entitled
National HIV Behavioral Surveillance
System Among Transgender Women
(NHBS-Trans). CDC did not receive
comments related to the previous
notice. The current notice serves to
allow an additional 30 days for public
and affected agency comments. The
project title has been revised to clarify
project goals.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
E:\FR\FM\07FEN1.SGM
07FEN1
2525
Federal Register / Vol. 84, No. 26 / Thursday, February 7, 2019 / Notices
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Barriers and Facilitators to Expanding
the NHBS to Conduct HIV Behavioral
Surveillance Among Transgender
Women (NHBS-Trans)—New—National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
The National HIV Behavioral
Surveillance System (NHBS, OMB No.
0920–0770, exp. 5/31/2020) is CDC’s
ongoing surveillance system to assess
HIV prevalence and factors associated
with HIV among populations at high
risk for HIV. NHBS has a 15-year record
of successfully reaching and recruiting
hidden populations, with a focus on
men who have sex with men, injection
drug users, and heterosexuals at high
risk of HIV infection.
CDC requests OMB approval to
conduct a two-year pilot study to
examine the feasibility of extending the
NHBS’s proven surveillance framework
to include transgender (TG) women, a
hidden subpopulation with a
disproportionately high burden of HIV.
Information will be collected in nine
geographically diverse U.S.
Metropolitan Statistical Areas (MSAs)
with high HIV prevalence: Atlanta, GA,
Dallas, TX, Los Angeles, CA, New
Orleans, LA, New York, NY,
Philadelphia, PA, San Francisco, CA,
Seattle, WA, and Washington, DC.
Together these sites accounted for over
33% of all persons living with HIV at
year end 2014 in large (>500,000
residents) MSAs. All NHBS-Trans sites
currently participate in the NHBS and
are familiar with its protocols for
respondent recruitment, information
collection, HIV testing, and referral to
services.
The NHBS-Trans pilot study will use
customized NHBS instruments,
sampling and recruitment methods to
assess barriers to, and best strategies for,
conducting HIV-related bio-behavioral
surveys among transgender women.
Information will be collected on HIV
risk behaviors, gaps in services, barriers
to service, and other experiences of
transgender women from racial and
ethnic minority populations. Potential
participants will be identified through
respondent-driven recruitment methods,
also called peer-based recruitment.
During the two-year information
collection period, each NHBS-Trans site
will recruit 200 respondents for a
computer-assisted personal interview.
The proposed respondents are adult
minority transgender women. After
completing the 40-minute interview,
each respondent will be offered a free,
rapid HIV test. Respondents will also be
asked to participate in short debriefing
interviews about their experiences with
recruiting additional participants. The
debriefing interviews will help CDC
understand the reasons why eligible
transgender women choose not to
participate in the NHBS-Trans pilot
study.
Over the two-year pilot period, the
target number of completed interviews
for all sites is 1,800 (200 per site). CDC
estimates that 1,980 individuals must be
screened in order to identify 1,800
individuals who meet eligibility criteria
and consent to participation.
Quantitative analysis of 1,800
interviews will be conducted using
SAS. Findings of the NHBS-Trans pilot
study will be used by CDC and local
health department staff to assess the
feasibility of using NHBS infrastructure
to monitor the prevalence of HIV among
transgender women of color and to
strengthen understanding of the
behavioral and environmental HIV risk
factors that contribute to the
disproportionately high prevalence of
HIV within this population. Improved
surveillance of transgender women is
necessary to help CDC and health
departments identify areas for
community-level interventions, track
the progress of communities in
implementing change, and evaluate
interventions that seek to reduce HIV
risk factors and increase engagement in
HIV prevention and care.
Participation in the NHBS-Trans
study is voluntary and there are no costs
to respondents other than their time.
The total estimated annualized burden
hours are 713.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of
respondents
Form
name
Number of
respondents
Transgender Women >18 years old ...............
Eligible and consenting participants ...............
Peer Recruiters ...............................................
Eligibility Screener ..........................................
NHBS-Trans Interview ...................................
Recruiter Debriefing Form ..............................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–01322 Filed 2–6–19; 8:45 am]
[30-Day–19–0210]
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled List of
Ingredients Added to Tobacco in the
VerDate Sep<11>2014
17:23 Feb 06, 2019
Jkt 247001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
990
900
900
Number of
responses per
respondent
1
1
1
Average
burden per
response
(in hours)
5/60
40/60
2/60
Manufacture of Cigarette Products to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on August 21, 2018 to obtain
comments from the public and affected
agencies. CDC received 2 comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
E:\FR\FM\07FEN1.SGM
07FEN1
]]>Agencies
[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2524-2525]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01322]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-19-18AAE]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Barriers and Facilitators to Expanding the
NHBS to Conduct HIV Behavioral Surveillance Among Transgender Women
(NHBS-Trans) to the Office of Management and Budget (OMB) for review
and approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on May 29,
2018 to obtain comments from the public and affected agencies. The
notice was entitled National HIV Behavioral Surveillance System Among
Transgender Women (NHBS-Trans). CDC did not receive comments related to
the previous notice. The current notice serves to allow an additional
30 days for public and affected agency comments. The project title has
been revised to clarify project goals.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or
[[Page 2525]]
send an email to omb@cdc.gov. Direct written comments and/or
suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide
written comments within 30 days of notice publication.
Proposed Project
Barriers and Facilitators to Expanding the NHBS to Conduct HIV
Behavioral Surveillance Among Transgender Women (NHBS-Trans)--New--
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The National HIV Behavioral Surveillance System (NHBS, OMB No.
0920-0770, exp. 5/31/2020) is CDC's ongoing surveillance system to
assess HIV prevalence and factors associated with HIV among populations
at high risk for HIV. NHBS has a 15-year record of successfully
reaching and recruiting hidden populations, with a focus on men who
have sex with men, injection drug users, and heterosexuals at high risk
of HIV infection.
CDC requests OMB approval to conduct a two-year pilot study to
examine the feasibility of extending the NHBS's proven surveillance
framework to include transgender (TG) women, a hidden subpopulation
with a disproportionately high burden of HIV. Information will be
collected in nine geographically diverse U.S. Metropolitan Statistical
Areas (MSAs) with high HIV prevalence: Atlanta, GA, Dallas, TX, Los
Angeles, CA, New Orleans, LA, New York, NY, Philadelphia, PA, San
Francisco, CA, Seattle, WA, and Washington, DC. Together these sites
accounted for over 33% of all persons living with HIV at year end 2014
in large (>500,000 residents) MSAs. All NHBS-Trans sites currently
participate in the NHBS and are familiar with its protocols for
respondent recruitment, information collection, HIV testing, and
referral to services.
The NHBS-Trans pilot study will use customized NHBS instruments,
sampling and recruitment methods to assess barriers to, and best
strategies for, conducting HIV-related bio-behavioral surveys among
transgender women. Information will be collected on HIV risk behaviors,
gaps in services, barriers to service, and other experiences of
transgender women from racial and ethnic minority populations.
Potential participants will be identified through respondent-driven
recruitment methods, also called peer-based recruitment.
During the two-year information collection period, each NHBS-Trans
site will recruit 200 respondents for a computer-assisted personal
interview. The proposed respondents are adult minority transgender
women. After completing the 40-minute interview, each respondent will
be offered a free, rapid HIV test. Respondents will also be asked to
participate in short debriefing interviews about their experiences with
recruiting additional participants. The debriefing interviews will help
CDC understand the reasons why eligible transgender women choose not to
participate in the NHBS-Trans pilot study.
Over the two-year pilot period, the target number of completed
interviews for all sites is 1,800 (200 per site). CDC estimates that
1,980 individuals must be screened in order to identify 1,800
individuals who meet eligibility criteria and consent to participation.
Quantitative analysis of 1,800 interviews will be conducted using
SAS. Findings of the NHBS-Trans pilot study will be used by CDC and
local health department staff to assess the feasibility of using NHBS
infrastructure to monitor the prevalence of HIV among transgender women
of color and to strengthen understanding of the behavioral and
environmental HIV risk factors that contribute to the
disproportionately high prevalence of HIV within this population.
Improved surveillance of transgender women is necessary to help CDC and
health departments identify areas for community-level interventions,
track the progress of communities in implementing change, and evaluate
interventions that seek to reduce HIV risk factors and increase
engagement in HIV prevention and care.
Participation in the NHBS-Trans study is voluntary and there are no
costs to respondents other than their time. The total estimated
annualized burden hours are 713.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Transgender Women >18 years old.... Eligibility Screener....... 990 1 5/60
Eligible and consenting NHBS-Trans Interview....... 900 1 40/60
participants.
Peer Recruiters.................... Recruiter Debriefing Form.. 900 1 2/60
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-01322 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P
